A COMPARATIVE CLINICAL EVALUATION OF KATPHALADI CHURNA AND PIPPALYADI CHURNA IN MANAGEMENT OF TAMAKA SWASA
Since time immemorial man has been in a constant endeavor to find the solutions for the life-threatening and ago- nizing disorders, which afflicts the human race. One such condition is ‘Tamaka swasa’1 which is known by the name Bronchial Asthma in modern parlance, wherein remissions and exacerbations are the typical features, leav- ing the patient in a pathetic situation. The Objective of the study is to evaluate the comparative efficacy of Kat- phaladi Churna7 and Pippalyadi Churna8 in the management of Tamaka Swasa through subjective and objective parameters. The present study registers 40 out of 64 patients. Out of these 24 patients were discontinued. The re- maining 40 patients of Tamaka Swasa fulfilling the criteria of diagnosis and inclusive criteria were included in the study, fewer than two groups as distributed patients in Group–A are 20 patients and Group–B is 20 patients. While comparing between the group result shows that Pippalyadi Churna is statistically more effective in Swasa Krichrata (Dyspnoea), Pratishaya (Rhinorrhea), Kanthodavamsa (Hoarseness of voice) and AEC than the Kat- phaladi Churna. In the overall result, Pippalyadi Churna is more effective than the Katphaladi Churna in the management of Tamaka Swasa. Both of the trial drugs proved to be a safe and effective oral formulation, which helps in the management of Tamaka swasa, when the disease is not too advanced and not associated with compli- cations also when correctly used by the patient as per instructions. Keywords: Tamaka Swasa, Swasa Krichrata, Pratishaya, Kanthodavamsa, AEC, Katphaladi Churna and Pip- palyadi Churna.